A Review of the Utility and Limitations of Artificial Intelligence in Retinal Disorders and Pediatric Ophthalmology
Guardado en:
| Publicado en: | Cureus vol. 16, no. 10 (2024) |
|---|---|
| Autor principal: | |
| Otros Autores: | , , |
| Publicado: |
Springer Nature B.V.
|
| Materias: | |
| Acceso en línea: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3122856617 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2168-8184 | ||
| 022 | |a 2154-4786 | ||
| 024 | 7 | |a 10.7759/cureus.71063 |2 doi | |
| 035 | |a 3122856617 | ||
| 045 | 2 | |b d20240101 |b d20241231 | |
| 100 | 1 | |a Labib, Kristie M | |
| 245 | 1 | |a A Review of the Utility and Limitations of Artificial Intelligence in Retinal Disorders and Pediatric Ophthalmology | |
| 260 | |b Springer Nature B.V. |c 2024 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a Artificial intelligence (AI) is reshaping ophthalmology by enhancing diagnostic precision and treatment strategies, particularly in retinal disorders and pediatric ophthalmology. This review examines AI's efficacy in diagnosing conditions such as diabetic retinopathy (DR) and age-related macular degeneration (AMD) using imaging techniques, such as optical coherence tomography (OCT) and fundus photography. AI also shows promise in pediatric care, aiding in the screening of retinopathy of prematurity (ROP) and the management of conditions, including pediatric cataracts and strabismus. However, the integration of AI in ophthalmology presents challenges, including ethical concerns regarding algorithm biases, privacy issues, and limitations in data set quality. Addressing these challenges is crucial to ensure AI's responsible and effective deployment in clinical settings. This review synthesizes current research, underscoring AI's transformative potential in ophthalmology while highlighting critical considerations for its ethical use and technological advancement. | |
| 610 | 4 | |a Food & Drug Administration--FDA | |
| 653 | |a Disease management | ||
| 653 | |a Ophthalmology | ||
| 653 | |a Diabetes | ||
| 653 | |a Accuracy | ||
| 653 | |a Artificial intelligence | ||
| 653 | |a Macular degeneration | ||
| 653 | |a Diabetic retinopathy | ||
| 653 | |a Retina | ||
| 653 | |a Neural networks | ||
| 653 | |a Medical personnel | ||
| 653 | |a Brain | ||
| 653 | |a Biomarkers | ||
| 653 | |a Eye diseases | ||
| 653 | |a Pathology | ||
| 653 | |a Pediatrics | ||
| 653 | |a Adults | ||
| 700 | 1 | |a Ghumman Haider | |
| 700 | 1 | |a Jain Samyak | |
| 700 | 1 | |a Jarstad, John S | |
| 773 | 0 | |t Cureus |g vol. 16, no. 10 (2024) | |
| 786 | 0 | |d ProQuest |t Health & Medical Collection | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3122856617/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/3122856617/fulltext/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3122856617/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |